D R Kafle1, K K Oli2. 1. Department of Internal Medicine, Nobel Medical College, Biratnagar, Nepal. 2. Department of Neurology, Institute of Medicine, TUTH, Kathmandu, Nepal.
Abstract
BACKGROUND: Epilepsy is a common and diverse disorder with many different causes. Outcomes are varied with 60-70% of newly diagnosed people rapidly entering remission after starting treatment and 20-30% developing a drug-resistant epilepsy with consequent clinical and psychosocial distress. About one third of patients with a first unprovoked seizure will have further seizures within five years, and about three quarters of those with two or three unprovoked seizures have further seizures within four years. OBJECTIVE: The aim of the study was to find out those factors which were associated with recurrence of seizure in Nepalese population. METHOD: It is a Descriptive Cross-sectional study which was conducted in Tribhuvan University Teaching Hospital from January 2013 to January 2014. RESULT: A total of 150 patients participated in the study. Neuroimaging was normal in 65(43.3%) patients. 48(32%) patients had neurocystercosis in their brain imaging, neuroinfection in 12(8%) of cases, cerebral infarction in 12(8%), Cerebral atrophy in 5(3.3%) patients, brain tumor in 4(2.7%), Mesial temporal sclerosis in 2(1.3%), tuberous sclerosis in 1(0.7%) and hypoxic brain injury in 1 (0.7%) patient. 14(9.3%) patients reported having a family history of epilepsy in first degree relative. There was statistically significant association between higher number of seizures before starting medication and increased frequency of seizure after starting medication (p<0.001). CONCLUSION: Most of the patients with recurrent seizure had identifiable cause. Neurocysticercosis was the most common cause. Higher number of seizure before starting medication was associated with increased frequency of seizure after starting medication.
BACKGROUND:Epilepsy is a common and diverse disorder with many different causes. Outcomes are varied with 60-70% of newly diagnosed people rapidly entering remission after starting treatment and 20-30% developing a drug-resistant epilepsy with consequent clinical and psychosocial distress. About one third of patients with a first unprovoked seizure will have further seizures within five years, and about three quarters of those with two or three unprovoked seizures have further seizures within four years. OBJECTIVE: The aim of the study was to find out those factors which were associated with recurrence of seizure in Nepalese population. METHOD: It is a Descriptive Cross-sectional study which was conducted in Tribhuvan University Teaching Hospital from January 2013 to January 2014. RESULT: A total of 150 patients participated in the study. Neuroimaging was normal in 65(43.3%) patients. 48(32%) patients had neurocystercosis in their brain imaging, neuroinfection in 12(8%) of cases, cerebral infarction in 12(8%), Cerebral atrophy in 5(3.3%) patients, brain tumor in 4(2.7%), Mesial temporal sclerosis in 2(1.3%), tuberous sclerosis in 1(0.7%) and hypoxic brain injury in 1 (0.7%) patient. 14(9.3%) patients reported having a family history of epilepsy in first degree relative. There was statistically significant association between higher number of seizures before starting medication and increased frequency of seizure after starting medication (p<0.001). CONCLUSION: Most of the patients with recurrent seizure had identifiable cause. Neurocysticercosis was the most common cause. Higher number of seizure before starting medication was associated with increased frequency of seizure after starting medication.
Authors: Kate Brizzi; Sonam Pelden; Tshokey Tshokey; Damber K Nirola; Megan B Diamond; Joshua P Klein; Lhab Tshering; Sonam Deki; Dechen Nidup; Veronica Bruno; Pierre Dorny; Hector Hugo Garcia; Farrah J Mateen Journal: Trans R Soc Trop Med Hyg Date: 2016-09 Impact factor: 2.184
Authors: Abhijit G Honavar; Abhipsha Anuranjana; Annsmol P Markose; Kapil Dani; Bijesh Yadav; Kundavaram P P Abhilash Journal: J Family Med Prim Care Date: 2019-12-10